Laparoscopy has been shown to be a safe and effective option for many diverse pelvic organ diseases, but how does the procedure fare during pregnancy? Due to the absence of large, comparative studies in pregnancy, there has been no definitive answer to this question. Now, researchers from Korea have found that laparoscopic surgeries can be safely used in women who are pregnant. Their results have been published in The Australian and New Zealand Journal of Obstetrics and Gynaecology.
Heidi Anne Duerr, MPH
Human papillomavirus vaccines provide still some benefit to women who have undergone treatment for HPV-related diseases, according to a new study published in the British Medical Journal.
Fatigue, which can plague patients’ years after cancer treatment has ended, may be the result of inflammation. Now, a new study published in the Journal of Clinical Oncology has found that omega-3 may help reduce fatigue associated with inflammation in these patients.
Women with a history of breast cancer have a one in five chance that the cancer will recur within 10 years of treatment. With that in mind, researchers have developed a blood test that can detect cancer recurrence sooner and with more sensitivity than previous blood tests.
Magnetic resonance imaging can be helpful and cost-effective in detecting breast cancer in certain patient populations, according to new research presented at the 8th European Breast Cancer Conference in Vienna, Austria.
Nonsteroidal antiinflammatory drugs are relatively safe during pregnancy, according to new research published in the American Journal of Obstetrics and Gynecology.
In the largest study to date looking at botulinum toxin for this use, the agent was found to an effective and safe treatment option for detrusor overactivity (DO). The results can be found in European Urology.
Which pharmacological and nonpharmacological options are safe and effective in reducing pain during labor?
Ovarian hyperstimulation syndrome (OHSS) appears in 3% to 8% of in vitro fertilization cycles. Now, new research shows that cabergoline, a dopamine agonist, can be effective in preventing OHSS in this patient population.
Premenstrual dysphoric disorder lasts longer than originally thought and is associated with at least four significant symptoms, according to a new research published in the Archives of General Psychiatry.